Italian real-life experience of omalizumab-Reference-Cited by-同舟云学术

Italian real-life experience of omalizumab

Published:2010-10 Issue:10 Volume:104 Page:1410-1416
ISSN:0954-6111
Container-title:Respiratory Medicine
language:en
Short-container-title:Respiratory Medicine

Author:

Cazzola M.,Camiciottoli G.,Bonavia M.,Gulotta C.,Ravazzi A.,Alessandrini A.,Caiaffa M.F.,Berra A.,Schino P.,Di Napoli P.L.,Maselli R.,Pelaia G.,Bucchioni E.,Paggiaro P.L.,Macchia L.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference14 articles.

1. Persistent asthma: disease control, resource utilisation and direct costs;Van Ganse;Eur Respir J,2002

2. The costs of asthma;Barnes;Eur Respir J,1996

3. Relationship between omalizumab pharmacokinetics, IgE pharmacodynamics and symptoms in patients with severe persistent allergic IgE-mediated asthma;Lowe;Br J Clin Pharmacol,2009

4. The use of omalizumab in the treatment of severe allergic asthma: a clinical experience update;Holgate;Respir Med,2009

5. Omalizumab has a place in therapy for asthma disease management;Pesko;J Manag Care Pharm,2009

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Omalizumab as a long-term treatment for patients with severe asthma. Is it safe?: A ten-year study;The Egyptian Journal of Chest Diseases and Tuberculosis;2024-01

2. Omalizumab: a quarter of a century in the fight against T2-inflammatory diseases of upper and lower respiratory tract;Meditsinskiy sovet = Medical Council;2023-11-16

3. Omalizumab for Chinese patients with moderate-to-severe allergic asthma in real-world clinical setting: a prospective, observational study;BMJ Open Respiratory Research;2023-09

4. Long-Term Safety of Omalizumab in Children with Asthma and/or Chronic Spontaneous Urticaria: A 4-Year Prospective Study in Real Life;Journal of Personalized Medicine;2023-06-29

5. Cytokine-targeted therapies for asthma and COPD;European Respiratory Review;2023-04-19